Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
Fatigue Common in People With HIV, Often Linked to Psychological Factors
Activist Group Claims HIV Cure Is Closer Than Many Think
HIV Eradication: One Step Closer
Atripla Co-pay Program to Cover More People
FDA Panel to Decide Fate of Egrifta, a Promising Gut Fat Fighter
Strategies for a Cure Reviewed in Vienna
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

April 5, 2010

San Francisco Endorses Starting HIV Treatment Immediately After Diagnosis

San Francisco public health doctors are urging patients to begin taking HIV medications soon after their diagnosis rather than waiting until their immune systems become compromised, The New York Times reports. The city’s Department of Public Health will announce the new testing guidelines this week.

According to the article, the policy shift was prompted by evidence that patients who start antiretroviral treatment earlier are more likely to live longer and less likely to develop illnesses—such as heart disease, kidney failure and cancer—that are common among long-term survivors. A recent study in The New England Journal of Medicine found that patients who put off therapy until their immune system started failing had a nearly twofold greater risk of dying—from any cause—than those who began treatment when their CD4 counts were above 500.

Under San Francisco’s new policy, doctors will offer patients combination therapy and advise them to pursue early treatment, but the patients will ultimately decide whether to begin therapy right after their diagnosis.

“The history of HIV disease has always been about change,” said Diane V. Havlir, MD, chief of the HIV/AIDS division at San Francisco General Hospital. “We pride ourselves on working quickly with new data.”

Health experts also argue that early treatment will curb new infections by reducing viral loads in HIV-positive San Franciscans and thereby reducing their risk of transmitting the virus to their negative partners.

“I do anticipate it will drive down the rates of new infections,” said Mitchell H. Katz, MD, the city’s director of public health. “It’s a nice, secondary benefit of this new policy.”

Others experts argue that while newer HIV medications are less toxic than earlier regimens, the long-term effects of these new drugs remain unknown.

Jay Levy, MD, a San Francisco virologist with the University of California, was one of the first to discover HIV. He’s skeptical of the city’s new policy.

As he told the Times: “It’s just too risky.”

Search: San Francisco, HIV, treatment, diagnosis, patients, doctors, immune system, illness


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Kevin, Phoenix, 2010-04-06 17:05:44
I'm glad I made the choice to go on HIV meds before my t cells dropped below 500. It's good to see the science support my personal choice. I have side effects from HIV, but no side effects from my meds (truvada and intelence).

DrTeddy, San Francisco, 2010-04-06 13:44:45
I agree with this policy as a public health doctor with emphasis on public health effects more than individual patient benefits. Definitely individual clients benefit from taking HIV meds sooner than later in the diagnosis, it is the long term side effects of the new HIV meds that's not yet known and may have unexpected consequences, that is concerning in this new direction.

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010


17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy